Palliative.org
Search Contact Us Home
Palliative Care Program Clinical Information Educational Opportunities Research General Public Resources
Clinical Information
 

 CLINICAL INFORMATION
ASSESSMENT TOOLS
PALLIATIVE CARE TIPS
JOURNAL WATCH
NURSING NOTES
EDITORIAL REFLECTIONS
PUBLICATIONS



  Palliative Care Tips

 

DYSPNEA Downloadable PDF file

Sharon Watanabe, MD, Tertiary Palliative Care Unit, Grey Nuns Community Hospital - Issue #4 (Collect them all) (re-issued with changes June 2005)

Dyspnea: an uncomfortable awareness of breathing a frequent and often devastating symptom of cancer and other end of life illness

Causes:
1.Direct effect of cancer, eg:

  • airway obstruction
  • pleural effusion
  • parenchymal lung involvement
  • pericardial effusion
  • lymphangitic carcinomatosis
  • superior vena cava obstruction
2.Indirect effects of cancer, eg:
  • pneumonia
  • anemia
  • pulmonary embolus
3.Cancer treatment, eg:
  • radiation - or chemotherapy-induced pneumonitis
4.Unrelated to cancer, eg:
  • chronic obstructive lung disease
  • congestive heart failure
  • motor neuron disease

Approach:
1. Determine underlying cause(s):

  • history and physical
  • chest x-ray
2. Treat underlying cause(s), if possible and clinically appropriate. Specific situations:
(a) Airway or SVC obstruction
  • consider radiotherapy (consult oncologist)
  • try dexamethasone 10 mg po/sc qid x 48 hrs; if effective, taper to minimal dose required
(b) Lymphangitic carcinomatosis
  • try dexamethasone
(c) Pleural effusion
  • consider thoracentesis; if effective, consider pleurodesis for recurrent effusion (consult respirologist/thoracic surgeon)
3.Treat symptom:
(a) Oxygen
  • may be of benefit even if saturation >90%
(b) Opioids
  • if already prescribed for pain, titrate to relieve dyspnea
  • if opioid naive, start morphine 5-10 mg po/2.5-5 mg sc q4h around the clock and 2.5-5 mg po/1.5-2.5 mg sc q1h prn titrate (remember laxatives and antiemetic)
  • nebulized opioids not proven to be effective
(c) Bronchodilators
  • if history of asthma, chronic obstructive lung diseases or smoking

(d) Midazolam

  • for intractable severe dyspnea
  • start at 1 mg/ hr sc titrate until patient sedated. Refer to Tips on Terminal Sedation

Remember that endpoint is relief of subjective dyspnea, not physical signs of respiratory effort (family may need to be educated).

REMEMBER: For referrals, questions, or telephone consultations call 496-1300 weekdays and weekends

 



 

 
Palliative Care Program Clinical Information Educational Opportunities Research General Public Resources

Our site has been optimized for browsers and Adobe Acrobat Reader versions 4.0 and higher.

Educational component supported by the Capital Health Authority Please send comments to the theteam@palliative.org

Copyright ©1996, 2001 Edmonton Regional Palliative Care Program, all rights reserved. Content is intended for a Canadian Audience. Use of this online service is subject to the disclaimer and the terms and conditions. We subscribe to the HONcode principles of the Health On the Net Foundation.

Developed by iNTER@CTIVE IMAGES

 AFFILIATES
University of Alberta Capital Heath Alberta Palliative Net